Actively Recruiting
SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER
Led by Sohag University · Updated on 2024-08-13
50
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The present study will be conducted to assess whether there is a direct benefit associated with modified-Graham's omentopexy (MGO), above and beyond the benefit associated with Graham's omentopexy (GO) in the treatment of perforated duodenal ulcers. We attempted to answer the question whether primary closure of the perforation in MGO will affect the outcome of surgery. Complication rates will be compared for the two alternative surgical procedures.
CONDITIONS
Official Title
SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients of any gender with a clinical diagnosis of perforated peptic ulcer (gastric or duodenal)
- Patients who are fit to undergo surgery
You will not qualify if you...
- Patients with a bleeding ulcer that needs additional control measures
- Patients with other diseases requiring surgery besides perforated peptic ulcer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag university Hospital
Sohag, Egypt
Actively Recruiting
Research Team
A
Adel A Abdrabou, Resident
CONTACT
A
Asem Elsani M Ali, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here